Glenview Trust’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
4,537
-86
-2% -$30.9K 0.02% 250
2025
Q4
$1.62M Buy
4,623
+12
+0.3% +$4.37K 0.03% 238
2025
Q3
$1.7M Sell
4,611
-14
-0.3% -$5.41K 0.03% 238
2025
Q2
$1.83M Buy
4,625
+255
+6% +$95.4K 0.03% 226
2025
Q1
$1.63M Sell
4,370
-12
-0.3% -$4.57K 0.03% 228
2024
Q4
$1.58M Buy
4,382
+33
+0.8% +$12.2K 0.03% 224
2024
Q3
$1.57M Sell
4,349
-9
-0.2% -$3.11K 0.03% 231
2024
Q2
$1.48M Buy
4,358
+281
+7% +$95.2K 0.03% 224
2024
Q1
$1.46M Buy
4,077
+24
+0.6% +$8.07K 0.03% 223
2023
Q4
$1.21M Buy
4,053
+170
+4% +$47.7K 0.03% 235
2023
Q3
$1.06M Buy
3,883
+113
+3% +$32.4K 0.03% 228
2023
Q2
$1.15M Buy
3,770
+94
+3% +$27.2K 0.03% 222
2023
Q1
$1.05M Buy
3,676
+200
+6% +$53.1K 0.03% 224
2022
Q4
$850K Sell
3,476
-46
-1% -$10.4K 0.03% 236
2022
Q3
$713K Sell
3,522
-25
-0.7% -$5.26K 0.03% 234
2022
Q2
$706K Buy
3,547
+21
+0.6% +$4.93K 0.03% 233
2022
Q1
$943K Sell
3,526
-2
-0.1% -$518 0.03% 209
2021
Q4
$944K Buy
3,528
+2,000
+131% +$525K 0.03% 206
2021
Q3
$403K Sell
1,528
-35
-2% -$9.36K 0.02% 293
2021
Q2
$406K Sell
1,563
-11
-0.7% -$2.81K 0.02% 299
2021
Q1
$383K Buy
1,574
+14
+0.9% +$3.36K 0.02% 304
2020
Q4
$382K Sell
1,560
-326
-17% -$73.8K 0.02% 269
2020
Q3
$393K Sell
1,886
-36
-2% -$7K 0.02% 248
2020
Q2
$346K Sell
1,922
-4
-0.2% -$738 0.02% 261
2020
Q1
$321K Sell
1,926
-84
-4% -$16.4K 0.02% 252
2019
Q4
$422K Buy
2,010
+414
+26% +$85.9K 0.02% 257
2019
Q3
$345K Hold
1,596
0.02% 272
2019
Q2
$328K Sell
1,596
-5
-0.3% -$955 0.02% 278
2019
Q1
$316K Hold
1,601
0.02% 276
2018
Q4
$251K Buy
1,601
+430
+37% +$71.9K 0.02% 289
2018
Q3
$208K Buy
+1,171
New +$200K 0.01% 319
2018
Q2
Sell
-1,253
Closed -$202K 329
2018
Q1
$202K Buy
+1,253
New +$202K 0.01% 322
2014
Q4
$12.1M Buy
+128,044
New +$11.4M 1.29% 29
2013
Q4
$10.6M Buy
+140,509
New +$10.3M 1.21% 32

Other funds holding SYK

Glenview Trust's SYK Position: Q1 2026 in Review

Glenview Trust reduced its Stryker (SYK) stake by 1.9% in Q1 2026, selling an estimated $30.9K and leaving 4,537 shares worth $1.49M. The position accounts for 0.02% of the portfolio, ranked #250.

Glenview Trust first reported a position in SYK in Q4 2013 and has held it in 34 quarters since. The position peaked at $12.1M in Q4 2014. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Glenview Trust held 4,537 shares of Stryker worth $1.49M as of Q1 2026.
  • Glenview Trust sold 86 Stryker shares in Q1 2026, an estimated $30.9K.
  • Stryker made up 0.02% of Glenview Trust's portfolio in Q1 2026, its #250 holding.
  • Glenview Trust first reported a position in Stryker in Q4 2013 and has held it in 34 quarters since.
  • Glenview Trust's Stryker position peaked at $12.1M in Q4 2014.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.